US Patent Issued to CANCER RESEARCH TECHNOLOGY, KING'S COLLEGE LONDON, THE FRANCIS CRICK INSTITUTE on May 26 for "Expansion of non-haematopoietic tissue-resident gamma delta T cells and uses of these cells" (British Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,659, issued on May 26, was assigned to CANCER RESEARCH TECHNOLOGY Ltd. (London), KING'S COLLEGE LONDON (London) and THE FRANCIS CRICK INSTITUTE Ltd. (London).

"Expansion of non-haematopoietic tissue-resident gamma delta T cells and uses of these cells" was invented by Adrian Hayday (Kent, Great Britain), Oliver Nussbaumer (London) and Richard Woolf (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to the expansion of non-haematopoietic tissue-resident GammaDelta T cells in vitro by culturing lymphocytes obtained from non-haematopoietic tissue of humans or non-human animals in the presence of interleukin-2 (IL-2) and/or int...